Lisata Therapeutics, Inc. (LSTA) vs Satellos Bioscience Inc. (MSLE)
A side-by-side comparison of Lisata Therapeutics, Inc. and Satellos Bioscience Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
LSTA
Lisata Therapeutics, Inc.
$1.17HealthcareDelayed quote: Oct 6, 2026, 3:29 PM EDT
MSLE
Satellos Bioscience Inc.
$8.08HealthcareDelayed quote: Oct 6, 2026, 3:34 PM EDT
Total return — LSTA vs MSLE
growth of $100 · dividends reinvested · last 1yLSTA -40.3% (-40.3%/yr)MSLE +13.7% (+13.7%/yr)MSLE compounded faster over this window
LSTA MSLE
LSTA vs MSLE: by the numbers
- •LSTA is the larger company ($11M vs $10M market cap).
- •Both run net losses; MSLE's is the smaller (0.00% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | LSTA | MSLE |
|---|---|---|
| P/S ratio | 106.54 | N/A |
| P/B ratio | 1.29 | 0.17 |
Profitability
| Metric | LSTA | MSLE |
|---|---|---|
| Gross margin | 14.12% | 0.00% |
| Operating margin | -10711.18% | 0.00% |
| Net margin | -14621.00% | 0.00% |
| ROE | -177.35% | -57.34% |
| ROIC | -204.32% | -59.35% |
Growth (annualized)
| Metric | LSTA | MSLE |
|---|---|---|
| Total return CAGR (5Y) | -40.75% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.